DC Chemicals · Product datasheet

ARV-766 — Datasheet

CAT. NO. DC60447

Product page and current package options

ParameterValue
Chemical NameLuxdegalutamide
CAS No.2750830-09-0
Synonyms4-[4-[[1-[4-[[[trans-3-(4-Cyano-3-methoxyphenoxy)-2,2,4,4-tetramethylcyclobutyl]amino]carbonyl]phenyl]-4-piperidinyl]methyl]-1-piperazinyl]-N-[(3S)-2,6-dioxo-3-piperidinyl]-2-fluorobenzamide;ARV776;Luxdegalutamide
FormulaC45H54FN7O6
M.Wt807.951974391937
SMILESC(N[C@H]1CCC(=O)NC1=O)(=O)C1=CC=C(N2CCN(CC3CCN(C4=CC=C(C(N[C@@H]5C(C)(C)[C@@H](OC6=CC=C(C#N)C(OC)=C6)C5(C)C)=O)C=C4)CC3)CC2)C=C1F
Purity98%
Storage2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Biological Activity

ARV-766 is an orally active and potent proteolysis targeting chimera (PROTAC) protein degrader. ARV-766 degrades wild-type androgen receptor (AR) but also relevant AR LBD mutants, including the most prevalent AR L702H, H875Y, and T878A mutations[1].

In Vitro

No in vitro data are provided in the current product source. Contact us for further information.

In Vivo

No in vivo data are provided in the current product source. Contact us for further information.

References & source

[1]. Petrylak D P, et al. A phase 2 expansion study of ARV-766, a PROTAC androgen receptor (AR) degrader, in metastatic castration-resistant prostate cancer (mCRPC)[J]. 2023.

DC Chemicals original product information

Published experimental findings depend on the model and assay conditions. They do not guarantee equivalent performance in every application. For laboratory research use only.

Cart

Request quotation